Adult vaccination first: choose an age group or a medical condition to see what CDC's schedule shows. Below, the primary sources pharmacists use for schedules, labeling, safety reporting, travel health and practice, each with the date and method of its last check.
Adult immunization schedule
CDC adult schedule · addendum updated July 2, 2025 · matches CDC's live page, re-checked 12 Oct 2026 · About this view
19-26 years
Where CDC's chart changes category inside an age group, a vaccine appears under each category and is marked as part of the group.
Recommended vaccination for adults who meet age requirement, lack documentation of vaccination, or lack evidence of immunity
- COVID-19
1 or more doses of 2024–2025 vaccine (See Notes)
RxEvidence note: CDC's adult schedule tables and notes (addendum updated July 2, 2025) name 2024–2025 COVID-19 vaccines. CDC's COVID-19 page for health care providers (updated October 7, 2026) refers to 2026–2027 COVID-19 vaccines and to individual-based decision-making. These two CDC pages differ; open both. CDC's COVID-19 page for health care providers CDC's schedule note on COVID-19 - Influenza inactivated (IIV3, ccIIV3)
Influenza recombinant (RIV3)1 dose annually
- Influenza live, attenuated (LAIV3)
1 dose annually
- Tetanus, diphtheria, pertussis
(Tdap or Td)1 dose Tdap, then Td or Tdap booster every 10 years
- Measles, mumps, rubella
(MMR)1 or 2 doses depending on indication
(if born in 1957 or later) - Varicella
(VAR)2 doses (if born in 1980 or later)
- Human papillomavirus
(HPV)2 or 3 doses depending on age at initial vaccination or condition
- Hepatitis B
(HepB)2, 3, or 4 doses depending on vaccine or condition
- Inactivated poliovirus
(IPV)Complete 3-dose series if incompletely vaccinated. Self–report of previous doses acceptable (See Notes)
Recommended vaccination for adults with an additional risk factor or another indication
- Influenza inactivated
(aIIV3; HD–IIV3)
Influenza recombinant (RIV3)Solid organ transplant (See Notes)
- Respiratory Syncytial Virus
(RSV)Seasonal administration during pregnancy.
(See Notes)
- Tetanus, diphtheria, pertussis
(Tdap or Td)1 dose Tdap each pregnancy; 1 dose Td/Tdap for wound management (See Notes)
- Zoster recombinant
(RZV)2 doses for immunocompromising conditions
(See Notes) - Pneumococcal
(PCV15, PCV20,PCV21, PPSV23)CDC's chart shows this category here without further text; see CDC's notes for this vaccine. - Hepatitis A
(HepA)2, 3, or 4 doses depending on vaccine
- Meningococcal A, C, W, Y
(MenACWY)1 or 2 doses depending on indication (See Notes for booster recommendations)
- Meningococcal B
(MenB)2 or 3 doses depending on vaccine and indication (See Notes for booster recommendations)
CDC's chart shows this for part of this age group. - Haemophilus influenzae type b
(Hib)1 or 3 doses depending on indication
- Mpox
2 doses
Recommended vaccination based on shared clinical decision-making
- Meningococcal B
(MenB)19 through 23 years
CDC's chart shows this for part of this age group.
27-49 years
Where CDC's chart changes category inside an age group, a vaccine appears under each category and is marked as part of the group.
Recommended vaccination for adults who meet age requirement, lack documentation of vaccination, or lack evidence of immunity
- COVID-19
1 or more doses of 2024–2025 vaccine (See Notes)
RxEvidence note: CDC's adult schedule tables and notes (addendum updated July 2, 2025) name 2024–2025 COVID-19 vaccines. CDC's COVID-19 page for health care providers (updated October 7, 2026) refers to 2026–2027 COVID-19 vaccines and to individual-based decision-making. These two CDC pages differ; open both. CDC's COVID-19 page for health care providers CDC's schedule note on COVID-19 - Influenza inactivated (IIV3, ccIIV3)
Influenza recombinant (RIV3)1 dose annually
- Influenza live, attenuated (LAIV3)
1 dose annually
- Tetanus, diphtheria, pertussis
(Tdap or Td)1 dose Tdap, then Td or Tdap booster every 10 years
- Measles, mumps, rubella
(MMR)1 or 2 doses depending on indication
(if born in 1957 or later) - Varicella
(VAR)2 doses (if born in 1980 or later)
CDC's chart shows this for part of this age group. - Hepatitis B
(HepB)2, 3, or 4 doses depending on vaccine or condition
- Inactivated poliovirus
(IPV)Complete 3-dose series if incompletely vaccinated. Self–report of previous doses acceptable (See Notes)
Recommended vaccination for adults with an additional risk factor or another indication
- Influenza inactivated
(aIIV3; HD–IIV3)
Influenza recombinant (RIV3)Solid organ transplant (See Notes)
- Respiratory Syncytial Virus
(RSV)Seasonal administration during pregnancy.
(See Notes)
- Tetanus, diphtheria, pertussis
(Tdap or Td)1 dose Tdap each pregnancy; 1 dose Td/Tdap for wound management (See Notes)
- Varicella
(VAR)2 doses
CDC's chart shows this for part of this age group. - Zoster recombinant
(RZV)2 doses for immunocompromising conditions
(See Notes) - Pneumococcal
(PCV15, PCV20,PCV21, PPSV23)CDC's chart shows this category here without further text; see CDC's notes for this vaccine. - Hepatitis A
(HepA)2, 3, or 4 doses depending on vaccine
- Meningococcal A, C, W, Y
(MenACWY)1 or 2 doses depending on indication (See Notes for booster recommendations)
- Meningococcal B
(MenB)2 or 3 doses depending on vaccine and indication (See Notes for booster recommendations)
- Haemophilus influenzae type b
(Hib)1 or 3 doses depending on indication
- Mpox
2 doses
Recommended vaccination based on shared clinical decision-making
- Human papillomavirus
(HPV)27 through 45 years
CDC's chart shows this for part of this age group.
No Guidance/Not Applicable
Human papillomavirus (HPV)
50-64 years
Where CDC's chart changes category inside an age group, a vaccine appears under each category and is marked as part of the group.
Recommended vaccination for adults who meet age requirement, lack documentation of vaccination, or lack evidence of immunity
- COVID-19
1 or more doses of 2024–2025 vaccine (See Notes)
RxEvidence note: CDC's adult schedule tables and notes (addendum updated July 2, 2025) name 2024–2025 COVID-19 vaccines. CDC's COVID-19 page for health care providers (updated October 7, 2026) refers to 2026–2027 COVID-19 vaccines and to individual-based decision-making. These two CDC pages differ; open both. CDC's COVID-19 page for health care providers CDC's schedule note on COVID-19 - Influenza inactivated (IIV3, ccIIV3)
Influenza recombinant (RIV3)1 dose annually
- Tetanus, diphtheria, pertussis
(Tdap or Td)1 dose Tdap, then Td or Tdap booster every 10 years
- Measles, mumps, rubella
(MMR)1 or 2 doses depending on indication
(if born in 1957 or later) - Zoster recombinant
(RZV)2 doses
- Pneumococcal
(PCV15, PCV20,PCV21, PPSV23)CDC's chart shows this category here without further text; see CDC's notes for this vaccine. - Hepatitis B
(HepB)2, 3, or 4 doses depending on vaccine or condition
CDC's chart shows this for part of this age group. - Inactivated poliovirus
(IPV)Complete 3-dose series if incompletely vaccinated. Self–report of previous doses acceptable (See Notes)
Recommended vaccination for adults with an additional risk factor or another indication
- Influenza inactivated
(aIIV3; HD–IIV3)
Influenza recombinant (RIV3)Solid organ transplant (See Notes)
- Respiratory Syncytial Virus
(RSV)50 through 74 years (See Notes)
- Tetanus, diphtheria, pertussis
(Tdap or Td)1 dose Tdap each pregnancy; 1 dose Td/Tdap for wound management (See Notes)
- Varicella
(VAR)2 doses
- Hepatitis A
(HepA)2, 3, or 4 doses depending on vaccine
- Hepatitis B
(HepB)CDC's chart shows this category here without further text; see CDC's notes for this vaccine.CDC's chart shows this for part of this age group. - Meningococcal A, C, W, Y
(MenACWY)1 or 2 doses depending on indication (See Notes for booster recommendations)
- Meningococcal B
(MenB)2 or 3 doses depending on vaccine and indication (See Notes for booster recommendations)
- Haemophilus influenzae type b
(Hib)1 or 3 doses depending on indication
- Mpox
2 doses
No Guidance/Not Applicable
Influenza live, attenuated (LAIV3) · Human papillomavirus (HPV)
≥65 years
Where CDC's chart changes category inside an age group, a vaccine appears under each category and is marked as part of the group.
Recommended vaccination for adults who meet age requirement, lack documentation of vaccination, or lack evidence of immunity
- COVID-19
2 or more doses of 2024-2025 vaccine
RxEvidence note: CDC's adult schedule tables and notes (addendum updated July 2, 2025) name 2024–2025 COVID-19 vaccines. CDC's COVID-19 page for health care providers (updated October 7, 2026) refers to 2026–2027 COVID-19 vaccines and to individual-based decision-making. These two CDC pages differ; open both. CDC's COVID-19 page for health care providers CDC's schedule note on COVID-19
(See Notes) - Influenza inactivated (IIV3, ccIIV3)
Influenza recombinant (RIV3)1 dose annually
(HD–IIV3, RIV3, or aIIV3 preferred) - Influenza inactivated
(aIIV3; HD–IIV3)
Influenza recombinant (RIV3)1 dose annually
(HD–IIV3, RIV3, or aIIV3 preferred) - Respiratory Syncytial Virus
(RSV)≥75 years
CDC's chart shows this for part of this age group. - Tetanus, diphtheria, pertussis
(Tdap or Td)1 dose Tdap, then Td or Tdap booster every 10 years
- Measles, mumps, rubella
(MMR)CDC's chart shows this category here without further text; see CDC's notes for this vaccine.CDC's chart shows this for part of this age group. - Zoster recombinant
(RZV)2 doses
- Pneumococcal
(PCV15, PCV20,PCV21, PPSV23)See Notes
- Inactivated poliovirus
(IPV)Complete 3-dose series if incompletely vaccinated. Self–report of previous doses acceptable (See Notes)
Recommended vaccination for adults with an additional risk factor or another indication
- Respiratory Syncytial Virus
(RSV)CDC's chart shows this category here without further text; see CDC's notes for this vaccine.CDC's chart shows this for part of this age group. - Tetanus, diphtheria, pertussis
(Tdap or Td)1 dose Tdap each pregnancy; 1 dose Td/Tdap for wound management (See Notes)
- Varicella
(VAR)2 doses
- Hepatitis A
(HepA)2, 3, or 4 doses depending on vaccine
- Hepatitis B
(HepB)CDC's chart shows this category here without further text; see CDC's notes for this vaccine. - Meningococcal A, C, W, Y
(MenACWY)1 or 2 doses depending on indication (See Notes for booster recommendations)
- Meningococcal B
(MenB)2 or 3 doses depending on vaccine and indication (See Notes for booster recommendations)
- Haemophilus influenzae type b
(Hib)1 or 3 doses depending on indication
- Mpox
2 doses
Recommended vaccination based on shared clinical decision-making
- Pneumococcal
(PCV15, PCV20,PCV21, PPSV23)See Notes
No Guidance/Not Applicable
Influenza live, attenuated (LAIV3) · Measles, mumps, rubella (MMR) · Human papillomavirus (HPV)
Pregnancy
Recommended for all adults who lack documentation of vaccination, OR lack evidence of immunity
- Influenza inactivated
Influenza recombinant CDC's chart shows this category here without further text; see CDC's notes for this vaccine. - RSV
Seasonal administration. (See Notes)
- HepB
See Notes
Not recommended for all adults, but recommended for some adults based on either age OR increased risk for or severe outcomes from disease
Recommended for all adults, and additional doses may be necessary based on medical condition or other indications. See Notes.
Precaution: Might be indicated if benefit of protection outweighs risk of adverse reaction
Contraindicated or not recommended *Vaccinate after pregnancy, if indicated
No Guidance/Not Applicable
COVID-19 · RZV · Pneumococcal · MenACWY · Hib
Immuno-compromised (excluding HIV infection)
Recommended for all adults who lack documentation of vaccination, OR lack evidence of immunity
- Influenza inactivated
Influenza recombinantSolid organ transplant
(See Notes) - Tdap or Td
1 dose Tdap, then Td or Tdap booster every 10 yrs
- RZV
See Notes
- PneumococcalCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- IPV
Complete 3-dose series if incompletely vaccinated. Self–report of previous doses acceptable (See Notes)
Not recommended for all adults, but recommended for some adults based on either age OR increased risk for or severe outcomes from disease
Recommended for all adults, and additional doses may be necessary based on medical condition or other indications. See Notes.
- COVID-19
See Notes
RxEvidence note: CDC's adult schedule tables and notes (addendum updated July 2, 2025) name 2024–2025 COVID-19 vaccines. CDC's COVID-19 page for health care providers (updated October 7, 2026) refers to 2026–2027 COVID-19 vaccines and to individual-based decision-making. These two CDC pages differ; open both. CDC's COVID-19 page for health care providers CDC's schedule note on COVID-19 - Hib
HSCT: 3 dosesc
Contraindicated or not recommended *Vaccinate after pregnancy, if indicated
HIV infection CD4 percentage and count – <15% or <200/mm3
Recommended for all adults who lack documentation of vaccination, OR lack evidence of immunity
- Influenza inactivated
Influenza recombinant1 dose annually
- Tdap or Td
1 dose Tdap, then Td or Tdap booster every 10 yrs
- RZV
See Notes
- PneumococcalCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- HepACDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- HepBCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- IPV
Complete 3-dose series if incompletely vaccinated. Self–report of previous doses acceptable (See Notes)
Not recommended for all adults, but recommended for some adults based on either age OR increased risk for or severe outcomes from disease
Recommended for all adults, and additional doses may be necessary based on medical condition or other indications. See Notes.
- COVID-19
See Notes
RxEvidence note: CDC's adult schedule tables and notes (addendum updated July 2, 2025) name 2024–2025 COVID-19 vaccines. CDC's COVID-19 page for health care providers (updated October 7, 2026) refers to 2026–2027 COVID-19 vaccines and to individual-based decision-making. These two CDC pages differ; open both. CDC's COVID-19 page for health care providers CDC's schedule note on COVID-19 - MenACWYCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
Contraindicated or not recommended *Vaccinate after pregnancy, if indicated
HIV infection CD4 percentage and count – ≥15% and ≥200/mm3
Recommended for all adults who lack documentation of vaccination, OR lack evidence of immunity
- COVID-19CDC's chart shows this category here without further text; see CDC's notes for this vaccine.RxEvidence note: CDC's adult schedule tables and notes (addendum updated July 2, 2025) name 2024–2025 COVID-19 vaccines. CDC's COVID-19 page for health care providers (updated October 7, 2026) refers to 2026–2027 COVID-19 vaccines and to individual-based decision-making. These two CDC pages differ; open both. CDC's COVID-19 page for health care providers CDC's schedule note on COVID-19
- Influenza inactivated
Influenza recombinant1 dose annually
- Tdap or Td
1 dose Tdap, then Td or Tdap booster every 10 yrs
- MMRCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- VAR
See Notes
- RZV
See Notes
- PneumococcalCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- HepACDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- HepBCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- IPV
Complete 3-dose series if incompletely vaccinated. Self–report of previous doses acceptable (See Notes)
Not recommended for all adults, but recommended for some adults based on either age OR increased risk for or severe outcomes from disease
Recommended for all adults, and additional doses may be necessary based on medical condition or other indications. See Notes.
- MenACWYCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
Contraindicated or not recommended *Vaccinate after pregnancy, if indicated
- LAIV3CDC's chart shows this category here without further text; see CDC's notes for this vaccine.
Men who have sex with men
Recommended for all adults who lack documentation of vaccination, OR lack evidence of immunity
- COVID-19CDC's chart shows this category here without further text; see CDC's notes for this vaccine.RxEvidence note: CDC's adult schedule tables and notes (addendum updated July 2, 2025) name 2024–2025 COVID-19 vaccines. CDC's COVID-19 page for health care providers (updated October 7, 2026) refers to 2026–2027 COVID-19 vaccines and to individual-based decision-making. These two CDC pages differ; open both. CDC's COVID-19 page for health care providers CDC's schedule note on COVID-19
- Influenza inactivated
Influenza recombinant1 dose annually
- Tdap or Td
1 dose Tdap, then Td or Tdap booster every 10 yrs
- MMRCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- VARCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- HepACDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- HepBCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- IPV
Complete 3-dose series if incompletely vaccinated. Self–report of previous doses acceptable (See Notes)
Not recommended for all adults, but recommended for some adults based on either age OR increased risk for or severe outcomes from disease
- LAIV3
1 dose annually if age
19–49 years - RSVCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- RZVCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- HPVCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- PneumococcalCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- Mpox
See Notes
Asplenia, complement deficiency
Recommended for all adults who lack documentation of vaccination, OR lack evidence of immunity
- COVID-19CDC's chart shows this category here without further text; see CDC's notes for this vaccine.RxEvidence note: CDC's adult schedule tables and notes (addendum updated July 2, 2025) name 2024–2025 COVID-19 vaccines. CDC's COVID-19 page for health care providers (updated October 7, 2026) refers to 2026–2027 COVID-19 vaccines and to individual-based decision-making. These two CDC pages differ; open both. CDC's COVID-19 page for health care providers CDC's schedule note on COVID-19
- Influenza inactivated
Influenza recombinant1 dose annually
- Tdap or Td
1 dose Tdap, then Td or Tdap booster every 10 yrs
- MMRCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- VARCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- PneumococcalCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- Hib
Asplenia:
1 dose - IPV
Complete 3-dose series if incompletely vaccinated. Self–report of previous doses acceptable (See Notes)
Not recommended for all adults, but recommended for some adults based on either age OR increased risk for or severe outcomes from disease
- RSV
See Notes
- RZVCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- HPVCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- HepBCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- MpoxCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
Recommended for all adults, and additional doses may be necessary based on medical condition or other indications. See Notes.
Contraindicated or not recommended *Vaccinate after pregnancy, if indicated
- LAIV3CDC's chart shows this category here without further text; see CDC's notes for this vaccine.
No Guidance/Not Applicable
Heart or lung disease
Recommended for all adults who lack documentation of vaccination, OR lack evidence of immunity
- COVID-19CDC's chart shows this category here without further text; see CDC's notes for this vaccine.RxEvidence note: CDC's adult schedule tables and notes (addendum updated July 2, 2025) name 2024–2025 COVID-19 vaccines. CDC's COVID-19 page for health care providers (updated October 7, 2026) refers to 2026–2027 COVID-19 vaccines and to individual-based decision-making. These two CDC pages differ; open both. CDC's COVID-19 page for health care providers CDC's schedule note on COVID-19
- Influenza inactivated
Influenza recombinant1 dose annually
- Tdap or Td
1 dose Tdap, then Td or Tdap booster every 10 yrs
- MMRCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- VARCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- PneumococcalCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- IPV
Complete 3-dose series if incompletely vaccinated. Self–report of previous doses acceptable (See Notes)
Not recommended for all adults, but recommended for some adults based on either age OR increased risk for or severe outcomes from disease
- RSV
See Notes
- RZVCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- HPVCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- HepBCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- MpoxCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
Precaution: Might be indicated if benefit of protection outweighs risk of adverse reaction
- LAIV3
1 dose annually if age 19–
Kidney failure, End-stage renal disease or on dialysis
Recommended for all adults who lack documentation of vaccination, OR lack evidence of immunity
- COVID-19CDC's chart shows this category here without further text; see CDC's notes for this vaccine.RxEvidence note: CDC's adult schedule tables and notes (addendum updated July 2, 2025) name 2024–2025 COVID-19 vaccines. CDC's COVID-19 page for health care providers (updated October 7, 2026) refers to 2026–2027 COVID-19 vaccines and to individual-based decision-making. These two CDC pages differ; open both. CDC's COVID-19 page for health care providers CDC's schedule note on COVID-19
- Influenza inactivated
Influenza recombinant1 dose annually
- Tdap or Td
1 dose Tdap, then Td or Tdap booster every 10 yrs
- MMRCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- VARCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- PneumococcalCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- HepBCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- IPV
Complete 3-dose series if incompletely vaccinated. Self–report of previous doses acceptable (See Notes)
Not recommended for all adults, but recommended for some adults based on either age OR increased risk for or severe outcomes from disease
Precaution: Might be indicated if benefit of protection outweighs risk of adverse reaction
- LAIV3
1 dose annually if age 19–
Chronic liver disease; alcoholisma
Recommended for all adults who lack documentation of vaccination, OR lack evidence of immunity
- COVID-19CDC's chart shows this category here without further text; see CDC's notes for this vaccine.RxEvidence note: CDC's adult schedule tables and notes (addendum updated July 2, 2025) name 2024–2025 COVID-19 vaccines. CDC's COVID-19 page for health care providers (updated October 7, 2026) refers to 2026–2027 COVID-19 vaccines and to individual-based decision-making. These two CDC pages differ; open both. CDC's COVID-19 page for health care providers CDC's schedule note on COVID-19
- Influenza inactivated
Influenza recombinant1 dose annually
- Tdap or Td
1 dose Tdap, then Td or Tdap booster every 10 yrs
- MMRCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- VARCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- PneumococcalCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- HepACDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- HepBCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- IPV
Complete 3-dose series if incompletely vaccinated. Self–report of previous doses acceptable (See Notes)
Not recommended for all adults, but recommended for some adults based on either age OR increased risk for or severe outcomes from disease
- RSV
Liver disease
(See Notes) - RZVCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- HPVCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- MpoxCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
Precaution: Might be indicated if benefit of protection outweighs risk of adverse reaction
- LAIV3
1 dose annually if age 19–
Diabetes
Recommended for all adults who lack documentation of vaccination, OR lack evidence of immunity
- COVID-19CDC's chart shows this category here without further text; see CDC's notes for this vaccine.RxEvidence note: CDC's adult schedule tables and notes (addendum updated July 2, 2025) name 2024–2025 COVID-19 vaccines. CDC's COVID-19 page for health care providers (updated October 7, 2026) refers to 2026–2027 COVID-19 vaccines and to individual-based decision-making. These two CDC pages differ; open both. CDC's COVID-19 page for health care providers CDC's schedule note on COVID-19
- Influenza inactivated
Influenza recombinant1 dose annually
- Tdap or Td
1 dose Tdap, then Td or Tdap booster every 10 yrs
- MMRCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- VARCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- PneumococcalCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- HepBCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- IPV
Complete 3-dose series if incompletely vaccinated. Self–report of previous doses acceptable (See Notes)
Not recommended for all adults, but recommended for some adults based on either age OR increased risk for or severe outcomes from disease
Recommended based on shared clinical decision-making
- HepB
Age
≥ 60 years
Precaution: Might be indicated if benefit of protection outweighs risk of adverse reaction
- LAIV3
1 dose annually if age 19–
Health care Personnelb
Recommended for all adults who lack documentation of vaccination, OR lack evidence of immunity
- COVID-19CDC's chart shows this category here without further text; see CDC's notes for this vaccine.RxEvidence note: CDC's adult schedule tables and notes (addendum updated July 2, 2025) name 2024–2025 COVID-19 vaccines. CDC's COVID-19 page for health care providers (updated October 7, 2026) refers to 2026–2027 COVID-19 vaccines and to individual-based decision-making. These two CDC pages differ; open both. CDC's COVID-19 page for health care providers CDC's schedule note on COVID-19
- Influenza inactivated
Influenza recombinant1 dose annually
- Tdap or Td
1 dose Tdap, then Td or Tdap booster every 10 yrs
- MMRCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- VARCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- HepBCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- IPV
Complete 3-dose series if incompletely vaccinated. Self–report of previous doses acceptable (See Notes)
Not recommended for all adults, but recommended for some adults based on either age OR increased risk for or severe outcomes from disease
- LAIV3
49 years
- RSVCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- RZVCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- HPVCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- PneumococcalCDC's chart shows this category here without further text; see CDC's notes for this vaccine.
- Mpox
See Notes
CDC's footnotes for this table
- Precaution for LAIV4 does not apply to alcoholism.
- See notes for influenza; hepatitis B; measles, mumps, and rubella; and varicella vaccinations.
- Hematopoietic stem cell transplant.
About this view
Each entry is CDC's own cell text from its adult schedule, regrouped column by column; the headings are CDC's own legend wording. RxEvidence has not added, removed or reworded schedule content. Read it with CDC's notes, which hold dose intervals and conditions. Source: CDC, adult schedule by age. Source: CDC, adult schedule by medical condition or other indication. The same tables as CDC draws them, with every column side by side, are on the schedules page.
The re-check date means this copy was compared with CDC's live page and was identical; it does not mean CDC's page is current for every product or season.
Schedules and recommendations
- Immunization schedules for healthcare professionals (opens in a new tab)
CDC's index of the child and adolescent and adult immunization schedules.
Index page dated July 2, 2025; lists the child and adolescent and adult schedules by age.
- Child and adolescent immunization schedule by age (opens in a new tab)
CDC schedule for ages 18 years or younger, with links to PDF versions, notes and addendum.
Page title when checked: "Addendum updated July 2, 2025"; scope line: "Recommendations for Ages 18 Years or Younger, United States, 2025".
- Catch-up immunization schedule for children and adolescents (opens in a new tab)
Catch-up schedule (a table within the CDC child and adolescent schedule).
- Child and adolescent schedule by medical indication (opens in a new tab)
Schedule by medical indication (a table within the CDC child and adolescent schedule).
- Child and adolescent schedule notes (opens in a new tab)
The notes that accompany the CDC child and adolescent schedule.
- Adult immunization schedule by age (opens in a new tab)
CDC schedule for ages 19 years or older, with links to PDF versions, notes and addendum.
Page title when checked: "Addendum updated July 2, 2025"; scope line: "Recommendations for Ages 19 Years or Older, United States, 2025".
- Adult schedule by medical condition and other indication (opens in a new tab)
Adult schedule by medical condition and other indication (a table within the CDC adult schedule).
- Adult schedule notes (opens in a new tab)
The notes that accompany the CDC adult schedule.
- AAP immunization policy and schedule (opens in a new tab)
The AAP's immunization pages, which list its Recommended Childhood and Adolescent Immunization Schedule: United States, 2026.
Schedule listed as "Recommended Childhood and Adolescent Immunization Schedule: United States, 2026"; the page does not state a publication date for the schedule.
- AAP childhood and adolescent immunization schedule (PDF) (opens in a new tab)
PDF of the AAP schedule, as linked from the AAP immunization page.
- Advisory Committee on Immunization Practices (ACIP) (opens in a new tab)
CDC's ACIP home page: recommendations, meeting information, membership and workgroups.
- ACIP recommendations (opens in a new tab)
CDC's listing of ACIP vaccine recommendations.
- ACIP meeting information (opens in a new tab)
Meeting dates, agendas and materials for ACIP meetings.
- Morbidity and Mortality Weekly Report (MMWR) (opens in a new tab)
CDC's weekly scientific publication, the Morbidity and Mortality Weekly Report.
- Vaccines licensed for use in the United States (opens in a new tab)
FDA's alphabetical list of licensed vaccines, each linking to its FDA product page. Licensure alone does not establish current commercial availability.
Page shows "Content current as of: 10/08/2026"; no machine-readable list or feed is offered on the page.
Vaccine information
- DailyMed (opens in a new tab)
The National Library of Medicine's database of current FDA-approved product labeling, including vaccine package inserts.
- Vaccine Information Statements (VIS) (opens in a new tab)
CDC's current Vaccine Information Statements, the documents providers give to vaccine recipients.
- Vaccine Information Statements in English and other languages (opens in a new tab)
Immunize.org's collection of VISs, including translations.
- Epidemiology and Prevention of Vaccine-Preventable Diseases (Pink Book) (opens in a new tab)
CDC's reference text on vaccine-preventable diseases and vaccines; this is its table of contents.
- Vaccine storage and handling (opens in a new tab)
CDC's guidance on vaccine storage and handling.
- Vaccine Adverse Event Reporting System (VAERS) (opens in a new tab)
The national system for reporting adverse events after vaccination.
- National Vaccine Injury Compensation Program (opens in a new tab)
HRSA's page for the program that compensates people with covered vaccine injuries.
- Clinical Decision Support for Immunization (CDSi) (opens in a new tab)
CDC's logic specification, supporting data and test cases that immunization information systems and software use to compute recommendations.
When checked: logic specification version 4.6 (updated December 2024); supporting data version 4.65 (updated August 2026); test cases: healthy childhood and adult v4.46 (August 2026), underlying conditions v4.6 (September 2025). The page states no terms of use.
Travel health
Official destination-specific guidance for travelers.
- Travelers' Health (opens in a new tab)
CDC's Travelers' Health site: destination pages and travel health notices.
- CDC Yellow Book (opens in a new tab)
CDC's health information for international travel.
Pharmacist practice
- Immunize.org clinical resources (opens in a new tab)
Immunize.org's clinical resources for vaccine providers.
- Rhode Island Department of Health: Immunization (opens in a new tab)
The Rhode Island Department of Health's immunization page.
No source matches that filter. Clear it to see all 27.
Source: Centers for Disease Control and Prevention (CDC). This material is copied from CDC's website, which offers it at no charge, and is shown as CDC wrote it. RxEvidence is not affiliated with CDC, the Department of Health and Human Services, or the U.S. Government, and this use does not imply their endorsement of RxEvidence or any product, service or organization. Reference to specific commercial products, manufacturers, companies, or trademarks does not constitute its endorsement or recommendation by the U.S. Government, Department of Health and Human Services, or Centers for Disease Control and Prevention. CDC revises these pages; CDC's page is the authority and takes precedence over this copy.
